Copyright
©The Author(s) 2025.
World J Gastrointest Surg. May 27, 2025; 17(5): 107579
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.107579
Published online May 27, 2025. doi: 10.4240/wjgs.v17.i5.107579
Table 2 Clinical outcomes of neoadjuvant chemotherapy, n (%)
| TG (n = 122) | PG (n = 122) | P value | |
| NACT regimen | 0.778 | ||
| SOX | 57 (46.72) | 61 (50.00) | |
| CAPEOX | 15 (12.30) | 15 (12.30) | |
| DOS | 20 (16.39) | 15 (12.30) | |
| FLOT | 10 (8.20) | 15 (12.30) | |
| FOLFOX | 5 (4.10) | 3 (2.46) | |
| Other | 15 (12.30) | 13 (10.66) | |
| NACT cycles | 0.251 | ||
| 1 | 4 (3.28) | 7 (5.74) | |
| 2 | 18 (14.75) | 14 (11.48) | |
| 3 | 37 (30.33) | 36 (29.51) | |
| 4 | 46 (37.70) | 56 (45.90) | |
| 6 | 13 (10.06) | 9 (7.38) | |
| > 6 | 4 (3.28) | 7 (5.74) | |
| TRG (Becker) | < 0.001 | ||
| 1a | 6 (4.92) | 21 (17.21) | |
| 1b | 19 (15.57) | 13 (10.66) | |
| 2 | 72 (59.02) | 30 (24.59) | |
| 3 | 25 (20.49) | 58 (47.54) | |
| CR response | 0.005 | ||
| CR | 4 (3.28) | 16 (13.11) | |
| Non-CR | 118 (96.72) | 106 (86.89) | |
| Plus immunotherapy | 0.797 | ||
| Yes | 23 (18.85) | 30 (24.59) | |
| No | 99 (81.15) | 92 (75.41) |
- Citation: Lu YM, Jin P, Wang HK, Shao XX, Hu HT, Jiang YJ, Li WY, Tian YT. Proximal gastrectomy with tubular stomach reconstruction vs total gastrectomy for proximal gastric cancer following neoadjuvant chemotherapy: A multicenter retrospective study. World J Gastrointest Surg 2025; 17(5): 107579
- URL: https://www.wjgnet.com/1948-9366/full/v17/i5/107579.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i5.107579